ClinicalTrials.gg
CompletedNCT04841590Updated Jun 11, 2025

Effects of Osteopathic Manual Therapy on Infant Colic

An interventional study of Intervention of the experimental group (EG) and Control Group (CG) in Colic, Infantile, sponsored by University of Seville. Completed at 3 sites in Spain. Open to participants aged 2 Weeks to 12 Weeks. Per ClinicalTrials.gov, last updated 2025-06-11.

Sponsored by University of Seville · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
2 Weeks to 12 Weeks
Sex
All
01

Study summary

Infant colic (CL) is a common disorder that affects approximately 8-33% of newborns during the first months of life. Typically defined as "crying that lasts at least 3 hours a day, and occurs at least 3 days a week over a 3-week period." Osteopathic manual therapy is presented as an effective and safe alternative to CL treatment.

The main objective of the study is to quantify possible changes in daily crying hours and hours of sleep, the severity of CL, the frequency of episodes, changes in stool and possible adverse effects.

The study hypothesis argues that the application of osteopathic manual therapy in babies with CL produces an improvement in the hours of daily crying, the frequency of episodes, the severity of colic and the hours of sleep. A controlled RCT will be performed where the evaluator and the parents will be blinded with respect to the allocation group for each subject. Subjects who meet the inclusion and exclusion criteria will be randomly assigned to the experimental group (EG) and control group (CG) using a table of random numbers by a person from outside the research. The EG diagnosis treatment using techniques of osteopathic manual therapy, vertebral mobilization, cranial techniques and visceral mobilization, according to the diagnostic criteria of the therapist. The CG has no treatment.

A total of 3 procedures were performed, one per week, problems with the chronology in all groups (days 0, 7 and 14 if required).

The therapist in charge of performing the operations will be a Physiotherapist and Osteopath with more than 10 years of experience.

The evaluations will be carried out by a healthcare professional with more than 10 years of experience. The evaluator will be blinded. Parents blinded with respect to the allocation group of each subject until the end of the study.

To analyze the main variable of the study (total hours of excessive crying per day), use the crying diary completed by the parents. The Infantile Colic Severity Questionnaire (ICSQ) will be applied to evaluate the secondary variables (sleep, feces, frequency of episodes and severity of colic).

02

Conditions studied

  • Colic, Infantile

Browse trials for

03

In context

Colic

127 studies on the registry are indexed under Colic; 18 are open to participants now.

This study's enrollment of 50 is below the median of 76 across 110 interventional studies indexed under Colic.

Browse Colic studies →

Lead sponsor

University of Seville is the lead sponsor of 130 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Weeks to 12 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inconsolable crying for more than 3 hours a day, at least 3 days a week for at least 3 weeks.
  • Age 2 - 12 weeks.
  • Gestation equal to or greater than 38 weeks.
  • Birth weight equal to or greater than 2,500 grams.
  • Weight gain of at least 150 grams. per week.
  • Appropriate pediatric general physical examination (height, weight, head circumference and psychomotor development).
  • Sign the .

Exclusion criteria

Exclusion Criteria:

  • Signs and / or symptoms of other pathologies.
  • Signs of lactose intolerance.
  • Having had benefits with the withdrawal of milk from maternal feeding or the use of milk with hydrolyzed casein.
  • Having received the subjects and / or siblings, previous treatment with Osteopathy and / or Chiropractic.
  • to the treatment and / or some of its techniques; presence of congenital malformations.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Experimental Group

    The experimental group (EG) will receive treatment through the use of manual physiotherapy techniques such as mobilization techniques in the spinal column, cranial techniques and visceral mobilization applied by gentle pressure, according to the therapist's diagnostic criteria after performing palpatory and mobility tests.

    Other: Intervention of the experimental group (EG)

  • Sham comparator
    Control Group

    The control group (CG) will not receive any treatment

    Other: Control Group (CG)

Interventions

  • OtherIntervention of the experimental group (EG)

    Treatment through the use of manual physiotherapy techniques such as mobilization techniques in the spinal column, cranial techniques and visceral mobilization applied by gentle pressure, according to the therapist's diagnostic criteria after performing palpatory and mobility tests.

  • OtherControl Group (CG)

    Subjects in the control group (CG) will not receive any treatment

06

What researchers measure

Primary outcomes

  1. Total hours of crying per day

    A crying diary completed by the parents will be used to compute the total hours per day that the subject presents crying.

    Time frame: At the beginning of the study (pre-intervention)

  2. Total hours of crying per day

    A crying diary completed by the parents will be used to compute the total hours per day that the subject presents crying.

    Time frame: 1 week after the first intervention

  3. Total hours of crying per day

    A crying diary completed by the parents will be used to compute the total hours per day that the subject presents crying.

    Time frame: 2 weeks after the first intervention

  4. Total hours of crying per day

    A crying diary completed by the parents will be used to compute the total hours per day that the subject presents crying.

    Time frame: 3 weeks after the first intervention

  5. Total hours of crying per day

    A crying diary completed by the parents will be used to compute the total hours per day that the subject presents crying.

    Time frame: Finally at 4 weeks from the first intervention

  6. Frequency of episodes

    The total number of crying episodes per day will be assessed using the Crying Diary completed by the parents.

    Time frame: At the beginning of the study (pre-intervention), 1 week after the first intervention, 2 weeks, 3 weeks and finally at 4 weeks from the beginning of the study

  7. Frequency of episodes

    The total number of crying episodes per day will be assessed using the Crying Diary completed by the parents.

    Time frame: 1 week after the first intervention

  8. Frequency of episodes

    The total number of crying episodes per day will be assessed using the Crying Diary completed by the parents.

    Time frame: 2 weeks after the first intervention

  9. Frequency of episodes

    The total number of crying episodes per day will be assessed using the Crying Diary completed by the parents.

    Time frame: 3 weeks after the first intervention

  10. Frequency of episodes

    The total number of crying episodes per day will be assessed using the Crying Diary completed by the parents.

    Time frame: Finally at 4 weeks from the first intervention

Secondary outcomes

  1. Colic Severity

    Severity will be assessed using the Infantile Colic Severity Questionnaire (ICSQ), a reliable and validated questionnaire for the diagnosis and evaluation of infant colic. The numerical values assigned to the responses suppose a score for each item that varies between 1-4 points, where 1 indicates "less seriousness" and 4 "more serious". The total score of the questionnaire is obtained by adding the value achieved in each item, which can range from 24 to 100 points.

    Time frame: At the beginning of the study (pre-intervention), 1 week after the first intervention, 2 weeks, 3 weeks and finally at 4 weeks from the beginning of the study

  2. Hours of sleep

    The total number of hours of sleep will be measured using the Infantile Colic Severity Questionnaire (ICSQ)

    Time frame: At the beginning of the study (pre-intervention), 1 week after the first intervention, 2 weeks, 3 weeks and finally at 4 weeks from the beginning of the study

  3. Stool

    Possible changes regarding this variable will be evaluated using the Infantile Colic Severity Questionnaire (ICSQ), a reliable and validated questionnaire for the diagnosis and evaluation of infant colic. The numerical values assigned to the responses suppose a score for each item that varies between 1-4 points, where 1 indicates "less seriousness" and 4 "more serious". The total score of the questionnaire is obtained by adding the value achieved in each item, which can range from 24 to 100 points.

    Time frame: At the beginning of the study (pre-intervention), 1 week after the first intervention, 2 weeks, 3 weeks and finally at 4 weeks from the beginning of the study

  4. Use of drugs

    It will be evaluated if the subjects take drugs at the beginning of the study, as well as the possible changes regarding this variable during the course of the study, using the Crying Diary completed by the parents.

    Time frame: At the beginning of the study (pre-intervention), 1 week after the first intervention, 2 weeks, 3 weeks and finally at 4 weeks from the beginning of the study

07

Study locations

3 sites
  • Clinica de Fisioterapia y Osteopatía M4
    Granada, 18003, Spain
  • Hospital del Sureste
    Madrid, 28500, Spain
  • Fisioterapia y Osteopatía David Nuñez
    Madrid, 28514, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04841590
Responsible party
David Nuñez Fernandez (Principal Investigator, University of Seville) — Principal investigator
First posted
Apr 12, 2021
Start date
Apr 1, 2021
Primary completion
Dec 30, 2024
Completion
Dec 30, 2024
Last update
Jun 11, 2025

Study contacts

David Nuñez Fernandez, PT, MsC
principal investigator · University of Seville

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion